Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin Lymphoma

This publication has 29 references indexed in Scilit:

• Mitosis-targeted anti-cancer therapies: where they stand
  Cell Death & Disease, 2012
• Cdk1/cyclin B plays a key role in mitotic arrest-induced apoptosis by phosphorylation of Mcl-1, promoting its degradation and freeing Bak from sequestration
  Biochemical Pharmacology, 2012
• Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
  Nature, 2011
• Cyclin-Dependent Kinase 1-Mediated Bcl-x_L/Bcl-2 Phosphorylation Acts as a Functional Link Coupling Mitotic Arrest and Apoptosis
  Molecular and Cellular Biology, 2010
• Targeting the Bcl-2 family of proteins in Hodgkin lymphoma:in vitrocytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737
  Leukemia & Lymphoma, 2009
• Pathobiology of Classical Hodgkin Lymphoma
  Pathobiology, 2006
• Microtubule-targeting agents in angiogenesis: Where do we stand?
  Drug Resistance Updates, 2006
• Bcl-2 Acts in a Proangiogenic Signaling Pathway through Nuclear Factor-κB and CXC Chemokines
  Cancer Research, 2005
• Angiogenic Potential of Prostate Carcinoma Cells Overexpressing bcl-2
  JNCI: Journal of the National Cancer Institute, 2001
• Universal control mechanism regulating onset of M-phase
  Nature, 1990